stockportfolio.pro
PACS Group, Inc. (PACS)
Healthcare · Medical Care Facilities · NYSE
PACS Group, Inc. revenue & earnings — last 4 fiscal years
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $2.42B | $3.11B | $4.09B | $5.29B |
| Gross profit | $400.68M | $447.07M | $507.69M | $780.33M |
| Net income | $150.50M | $112.87M | $55.76M | $191.54M |
| Net margin | 6.2% | 3.6% | 1.4% | 3.6% |
Source: PACS Group, Inc. SEC filings (10-K).
What growth is priced into PACS stock?
At today's market cap of $5.48B, PACS Group, Inc. is priced for free-cash-flow growth of about 15.5% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $155.07M from the FY ending 2025-12-31). This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 4 years of PACS Group, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track PACS in your portfolio →
PACS Group, Inc. financial history by metric
About PACS Group, Inc.
PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in the acquisition, ownership, and leasing of health care-related properties. PACS Group, Inc. was founded in 2013 and is headquartered in Salt Lake City, Utah.
PACS Group, Inc. — frequently asked questions
What is PACS Group, Inc.'s revenue?
PACS Group, Inc. (PACS) reported revenue of $5.29B for fiscal year 2025, up 29.3% from the prior year, according to its SEC filings.
Is PACS Group, Inc. profitable?
Yes. PACS earned net income of $191.54M in fiscal 2025, a net margin of 3.6%.
What is PACS's P/E ratio?
PACS Group, Inc. trades at a price-to-earnings ratio of about 22.3 based on the latest data in our nightly-refreshed cache.
How fast is PACS Group, Inc. growing?
PACS's revenue grew at roughly 29.7% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does PACS Group, Inc. have?
As of fiscal year 2025, PACS carried roughly $349.27M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is PACS Group, Inc.'s gross margin?
PACS's gross margin was 14.8% in fiscal 2025 — gross profit of $780.33M on revenue of $5.29B.
What is PACS Group, Inc.'s market cap?
PACS Group, Inc. (PACS) has a market capitalization of about $5.48B, based on the latest data in our nightly-refreshed cache.
When does PACS Group, Inc.'s fiscal year end?
PACS's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into PACS stock?
At today's market cap of $5.48B, PACS Group, Inc. is priced for free-cash-flow growth of about 15.5% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $155.07M from the FY ending 2025-12-31).
Where does this data come from?
All figures are computed from PACS Group, Inc.'s official SEC filings (10-K and 10-Q), covering 4 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.